SNV1521 in Participants With Advanced Solid Tumors
Start Date
2/23/2024
Completion Date
12/1/2027
Summary
This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the most effective and safe one. They are also investigating whether it can be combined with other cancer therapies.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
SNV1521
DB-1310
Abiraterone
Darolutamide
Conditions
Locations
Smilow Cancer Hospital at Yale New Haven
New Haven, Connecticut 06511
United States
Thomas Jefferson University
Philadelphia, Pennsylvania 19144
United States
Sarah Cannon Research Institute
Nashville, Tennessee 37203
United States
The University of Texas M.D. Anderson Cancer Center
Houston, Texas 77030
United States
START Center for Cancer Care
West Valley City, Utah 84119
United States
Scientia Clinical Research
Randwick, New South Wales 2031
Australia
Princess Alexandra Hospital
Woolloongabba, Queensland 4102
Australia
Monash Health
Clayton, Victoria 3168
Australia
The Alfred Hospital
Melbourne, Victoria 3004
Australia
Linear Clinical Research
Crawley, Western Australia 6009
Australia
The Institut Jules Bordet
Brussels, 1070
Belgium
University Center for Clinical Research Antwerp (UNICCRA)
Edegem, 2650
Belgium
AZ Maria Middelares
Ghent, 9000
Belgium
AZ Groeninge
Kortrijk, 8500
Belgium
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta T2N 5G2
Canada
Princess Margaret Hospital
Toronto, Ontario M5G 2M9
Canada
Institut Bergonie
Bordeaux, 33076
France
UNICANCER - Centre Leon-Berard (CLB)
Lyon, 69008
France
Gustave Roussy
Villejuif, 94805
France
Istituto Clinico Humanitas
Milan, 20089
Italy
Istituto Europeo di Oncologia (IEO) (European Institute of Oncology)
Milan, 20141
Italy
NEXT Oncology - Barcelona
Barcelona, 08023
Spain
Vall d'Hebron University Hospital
Barcelona, 08035
Spain
The START Center for Cancer Care - Madrid - CIOCC - Hospital Universitario Madrid Sanchinarro
Madrid, 28050
Spain
NEXT Oncology - Hospital Quironsalud Madrid
Madrid, 28223
Spain